We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
FR icon
326
First Industrial Realty Trust
FR
$7.95B
$2.47M 0.05%
51,214
-29,183
-36% -$1.39M
2018 Q3
17 quarters
ROSE
327
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
$2.47M 0.05%
236,311
-2,312
-1% -$23.7K
2021 Q4
4 quarters
JMAC
328
DELISTED
Maxpro Capital Acquisition Corp. Class A Common Stock
JMAC
$2.46M 0.05%
236,311
-2,312
-1% -$23.6K
2021 Q4
4 quarters
DSAQ icon
329
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$2.45M 0.05%
238,161
-2,331
-1% -$23.8K
2021 Q4
4 quarters
CURR icon
330
Currenc Group
CURR
$318M
$2.45M 0.05%
236,311
-2,312
-1% -$23.7K
2022 Q1
3 quarters
THAC
331
DELISTED
Thrive Acquisition Corporation Class A ordinary shares
THAC
$2.44M 0.05%
236,311
-2,312
-1% -$23.7K
2021 Q4
4 quarters
BRLS icon
332
Borealis Foods
BRLS
$21.2M
$2.44M 0.05%
236,311
-2,312
-1% -$23.6K
2021 Q4
4 quarters
ACDI
333
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
$2.44M 0.05%
236,311
-2,312
-1% -$23.6K
2022 Q1
3 quarters
FGMC
334
DELISTED
FG Merger Corp. Common Stock
FGMC
$2.44M 0.05%
227,558
-2,227
-1% -$22.5K
2022 Q2
2 quarters
CCTS icon
335
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$2.43M 0.04%
236,311
-2,312
-1% -$23.5K
2022 Q1
3 quarters
FAAS icon
336
DELISTED
DigiAsia
FAAS
$2.43M 0.04%
236,311
-2,312
-1% -$23.5K
2021 Q3
5 quarters
GTAC
337
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$2.43M 0.04%
236,311
-2,312
-1% -$23.5K
2022 Q1
3 quarters
SCMA
338
DELISTED
Seaport Calibre Materials Acquisition Corp. Class A Common Stock
SCMA
$2.43M 0.04%
236,311
-2,312
-1% -$23.4K
2022 Q1
3 quarters
RCFA icon
339
DELISTED
Perception Capital Corp. IV
RCFA
$2.42M 0.04%
236,311
-2,312
-1% -$23.5K
2022 Q1
3 quarters
FEXD icon
340
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$2.42M 0.04%
236,311
-2,312
-1% -$23.4K
2022 Q1
3 quarters
AVAC
341
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$2.42M 0.04%
236,311
-2,312
-1% -$23.4K
2021 Q4
4 quarters
MRT icon
342
Marti Technologies
MRT
$156M
$2.42M 0.04%
236,311
-2,312
-1% -$23.4K
2021 Q3
5 quarters
MSAI icon
343
MultiSensor AI
MSAI
$10.4M
$2.42M 0.04%
5,908
-58
-1% -$23.4K
2021 Q4
4 quarters
PEPL
344
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$2.42M 0.04%
236,311
-2,312
-1% -$23.3K
2021 Q4
4 quarters
SZZL icon
345
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$2.42M 0.04%
236,311
-2,312
-1% -$23.5K
2022 Q1
3 quarters
GNRC icon
346
Generac Holdings
GNRC
$12.9B
$2.41M 0.04%
+23,979
New +$2.71M
2022 Q4
0 quarters
DYN icon
347
Dyne Therapeutics
DYN
$2.98B
$2.41M 0.04%
208,191
+31,701
+18% +$367K
2022 Q1
3 quarters
ZURA icon
348
Zura Bio
ZURA
$381M
$2.41M 0.04%
236,311
-2,312
-1% -$23.4K
2021 Q3
5 quarters
CSTA
349
DELISTED
Constellation Acquisition Corp I
CSTA
$2.41M 0.04%
238,639
-2,345
-1% -$23.5K
2021 Q1
7 quarters
DRAY icon
350
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
$2.41M 0.04%
236,747
-2,317
-1% -$23.4K
2021 Q3
5 quarters
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.